From sample-to-report: Rapid MTB identification, drug resistance, and traceability solution

Full rapid process and reporting

Targeted and streamlined operation with MGI ATOPLEX technology

Full rapid process and reporting

Full rapid process and reporting

Suitable for culture-free sample

Suitable for culture-free sample

Comprehensive software analysis

Comprehensive software analysis

From sample-to-report: Rapid MTB identification, drug resistance, and traceability solution

Full rapid process and reporting

Targeted and streamlined operation with MGI ATOPLEX technology

Full rapid process and reporting

Full rapid process and reporting

Suitable for culture-free sample

Suitable for culture-free sample

Comprehensive software analysis

Comprehensive software analysis

From sample-to-report: Rapid MTB identification, drug resistance, and traceability solution

Full rapid process and reporting

Targeted and streamlined operation with MGI ATOPLEX technology

Full rapid process and reporting

Full rapid process and reporting

Suitable for culture-free sample

Suitable for culture-free sample

Comprehensive software analysis

Comprehensive software analysis

From sample-to-report: Rapid MTB identification, drug resistance, and traceability solution

Full rapid process and reporting

Targeted and streamlined operation with MGI ATOPLEX technology

Full rapid process and reporting

Full rapid process and reporting

Suitable for culture-free sample

Suitable for culture-free sample

Comprehensive software analysis

Comprehensive software analysis

Revolutionize Your Mycobacterium Tuberculosis Research with MGI's Cutting-Edge ATOPLEX & MTB-Explorer Software

Next Generation Sequencing has provided insights into the genetic diversity of Mycobacterium Tuberculosis, which are crucial for understanding the evolution and transmission of the disease, including the identification of drug-resistant strains, enabling rapid and accurate tailoring of treatment.

MGI has developed an ATOPlex Mycobacterium Tuberculosis targeted sequencing sample to report workflow, providing full and complete MTB identification and drug resistance analysis. Based on MGI’s ATOPlex multiplex PCR library preparation platform, 2-step amplification in one tube is needed to achieve target area amplification and library construction, supporting direct detection of nucleic acid extracted from sputum and lavage fluid samples.

Combined with MGI’s MTB-Explorer Software, provides identification of 174 types of mycobacteria, MTBC identification, spoligotyping, and evolutionary traceability analysis. Specifically for drug resistance, the software covers a total of 7000+ mutations, including all of the 1200+ first-and second-group drug resistance associated mutations associated with the “Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance" released by WHO for annotation.

MGI's ATOPlex Mycobacterium Tuberculosis targeted sequencing workflow Sample to report in as fast as 24h

Sample preperation
~7-8h
  • ATOPlex MTB Library Preperation Set

  • DNBSEQ OneStep Make DNB Reagent Kit V4.0 (Dua Barcode)

1

Sequencing
~12-20h
  • High-throughput Sequencing Set

  • DNBSEQ-G99 SM FCL PE150 12h

  • DNBSEQ-E25 FCL PE150 20h

2

Analysis
~2-6h
  • MTB-Explorer Software

3

MTB-Explorer Software

ATOPlex Mycobacterium Tuberculosis Targeted Sequencing

Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)

Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)
Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)
Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)
Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)
Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)
Precisely analyze and annotate drug resistance and explore with MTB-Explorer Software (ATOPLex)

Precision and Performance With DNBSEQ-G99 & DNBSEQ-E25

DNBSEQ-G99

DNBSEQ-E25

Samples per run icon
Samples per run

≤8 samples /FC

MGI Flow cells icon
Flow Cells

1

Read Lengths

FCL PE150

Nucleic Acid to report

30h

DNBSEQ-G99

DNBSEQ-E25

Samples per run icon
Samples per run

≤24 samples /FC

MGI Flow cells icon
Flow Cells

2

Read Lengths

FCL PE150

Nucleic Acid to report

24h

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Resources

Brochure & Manuals

Resources

Brochure & Manuals

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.